AAG
MRNA icon

Armstrong Advisory Group’s Moderna MRNA Stock Holding History

Armstrong Advisory Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4K Hold
263
– – ﹤0.01% 607
2026
Q1 		$13.4K Hold
263
– – ﹤0.01% 636
2025
Q4 		$7.76K Hold
263
– – ﹤0.01% 718
2025
Q3 		$6.79K Hold
263
– – ﹤0.01% 735
2025
Q2 		$7.26K Hold
263
– – ﹤0.01% 713
2025
Q1 		$10.9K Hold
263
– – ﹤0.01% 605
2024
Q4 		$10.9K Sell
263
-100
-28% -$4.78K ﹤0.01% 605
2024
Q3 		$24.3K Buy
363
+100
+38% +$9.18K ﹤0.01% 473
2024
Q2 		$31.2K Buy
263
+51
+24% +$6.45K ﹤0.01% 420
2024
Q1 		$21.1K Hold
212
– – ﹤0.01% 473
2023
Q4 		$21.1K Hold
212
– – ﹤0.01% 473
2023
Q3 		$21.9K Hold
212
– – ﹤0.01% 470
2023
Q2 		$25.8K Hold
212
– – ﹤0.01% 444
2023
Q1 		$32.6K Hold
212
– – ﹤0.01% 396
2022
Q4 		$38.1K Buy
+212
New +$34.7K 0.01% 371

Other funds holding MRNA

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
RA
REX Advisers Fairfield, Connecticut $37.3M AUM
BG
BDF Gestion Paris, France $747M AUM 47.35% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
MC
Mirabaud & Cie Geneva, Switzerland $249M AUM 43.75% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return